Answers are grounded in this paper and cite their sources.
Glioblastoma (GBM) brain tumors are among the most lethal of all human cancers, with a median survival of ~15 months. Standard-of-care radiologic methods fail to detect infiltrating GBM, which leads to undertreatment. We report a 2H MR method to better resolve/characterize GBM based on its enhanced uptake of branched-chain amino acids (e.g., leucine). We measure relaxation time constants for deuterated leucine in agarose phantoms and show the ability to detect d10-leucine at ~200 mM in a 4x4x4 mm3 voxel in phantoms. Finally, we demonstrated 2H MR measurement of enhanced deuterated leucine uptake in a rodent model of GBM.
No takes yet. Share an insight, caveat, or question.
McClendon et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: